Sign inJoin waitlistJoin the waitlist

Denise Uyar

Program Director · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · · ·

History

Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Gynecologic Oncology Division · Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Medical College of Wisconsin Affiliated Hospitals, Inc
Present

Cleveland Clinic
2005–2008
Obstetrics and Gynecology
University of Vermont Medical Center
2001–2005
Robert Larner College of Medicine
1993–1997

Research

A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer
Clinical Cancer Research · 2020 · 117 citations
Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer
Gynecologic Oncology · 2005 · First of 4 authors · 83 citations
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
Gynecologic Oncology · 2018 · 48 citations

Janet Rader
11 papers
William Bradley
7 papers
Elizabeth Hopp
6 papers · 1 as a resident
Erin Bishop
5 papers
Lindsey McAlarnen
5 papers · 5 as a fellow
Rebekah Summey
4 papers · 4 as a fellow
MM
Maurie Markman
3 papers
David Rahn
2 papers
Elizabeth Lokich
2 papers
GE
Gamal Eltabbakh
2 papers
Gena Dunivan
2 papers
Holly Richter
2 papers

Clinical trials

Immunogenicity of HPV Vaccine in Transplant Recipients.
Principal investigator · Active not recruiting · Phase 4
Medical College of Wisconsin
2023–2035
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Principal investigator · Completed · Phase 2
Medical College of Wisconsin
2016–2023
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Site PI · Recruiting · Phase 3
GOG Foundation
2024–2034